Matilda Chan is an Ophthalmology physician affiliated with University of California, San Francisco. OpenAlex indexes 74 publications with 1,735 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
95 Kirkham St
San Francisco, CA 941430001
Telephone
415-476-1442Registry record last updated 8 Jul 2007.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech, Inc.Program year20251 payment
- Amgen Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
73.1%Prostaglandin Analog27.1%Latanoprost100%Part D≥102 patientsCarbonic Anhydrase Inhibitor16.8%Dorzolamide-Timolol58%Dorzolamide Hcl42%Part D<11 patients+ 7 more classes in this area
Anti-infectives
13.2%Macrolide4%Erythromycin100%Part D≥21 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor3.1%Valacyclovir100%Part D<11 patients+ 3 more classes in this area
Cardiovascular
6.7%Beta blocker6.7%Timolol Maleate100%Part D≥33 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- Serum components to support corneal health
University of California, San Francisco
FY2026$205,000R21EY035829 - Analysis of chemical modulators for corneal endothelial dystrophies
University of California, San Francisco
FY2025$403,750R01EY032161 - Serum components to support corneal health
University of California, San Francisco
FY2025$246,000R21EY035829
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lysophosphatidic acid receptor 3 (LPAR3) regulates ocular surface chloride transport via calcium signaling
Experimental Eye Research
2025 - Optimized Protocol for Isolation and Culture of Primary Human Corneal Epithelial Cells
Translational Vision Science & Technology
2025 - Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody–Drug Conjugates (ADCs)
Current Ophthalmology Reports
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Emmanuelle Waubant, MD
University of California, San Francisco
Joel Palefsky, MD
University of California, San Francisco
Peter Hunt, MD
University of California, San Francisco
Owen Wolkowitz, MD
University of California, San Francisco
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Richard Spaide, MD
Vitreous Retina Macula Consultants of New York
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”